Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jul 2017

Zhang Zhaoxuan, Ye Shan, Zhang Min, Wu Jing, Yan Hong, Li Xiaojie, He Jie

Abstract excerpt

Dysregulation of SLC34A2 (NaPi2b) in tumors has attracted wide attention, but its expression and function in non-small cell lung cancer remains unclear. By examining its expression in lung adenocarcinoma and correlation to patient outcome, we aimed to explore its prognostic and therapeutic values in this deadly disease. Overall, 175 cases of lung adenocarcinoma sample were included in this study. Histological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anaplastic Lymphoma Kinase

Share to Biomarkers, Tumor

Share to ErbB Receptors

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 28720066
DOI: 10.1177/1010428317720212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients.PMID 28720066Read ↗

Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases.Semantic proximity Read ↗

Increased expression of SLC35F2 in non-small cell lung cancer predicts poor prognosisSemantic proximity Read ↗

CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma.Semantic proximity Read ↗

Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysisSemantic proximity Read ↗

Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinomaSemantic proximity Read ↗

Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinomaSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) in Pan-CancerSemantic proximity Read ↗

SLC11A2: a promising biomarker and therapeutic target in ovarian cancerSemantic proximity Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cellsSemantic proximity Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

ABCG2 predicts the prognosis and is associated with immune infiltration in lung cancer: a bioinformatics studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.